November 20, 2017 article Open access Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update Clinical Pharmacology & Therapeutics DOI: 10.1002/cpt.911 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 23 stored of 701 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access DPYD c.85 T > C, DPYD c.496 A>G, and DPYD c.2194 G>A and severe toxicity to fluoropyrimidines in PREPARE and Alpe-DPD trials. An original study and meta-analysis 2026 Pharmacological Research article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access 0 citations From Mila to Many: Making Ultra-Rare Disease Therapies More Accessible 2026 Inside Precision Medicine article Economics, Econometrics and Finance Pharmaceutical Economics and Policy 0 citations Pharmacokinetics of 5-Fluorouracil in Patients Treated With Capecitabine Carrying the c.1236G>A DPYD Variant Allele 2026 JCO Precision Oncology article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access 1 citations Reply to: Dihydropyrimidine Dehydrogenase Enzyme-Guided Dosing of 5-Fluorouracil: Prioritizing Precision Over Dose Reduction 2025 JCO Precision Oncology letter Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access 0 citations Integration of germline pharmacogenomic burden to predict fluoropyrimidine-related toxicity – A secondary analysis of the PREPARE trial 2025 Oncogene article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access 4 citations Real‐world study on fluoropyrimidine‐related toxicity outcomes in cancer patients with select DPYD variant alleles that received DPYD genotype‐guided dosing 2025 International Journal of Cancer article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access 6 citations Precision Treatment of Patients With GI Cancer Using Pre-emptive DPYD Genotyping/Phenotyping Plus Pharmacokinetic-Guided Dosing of 5-Fluorouracil 2025 JCO Precision Oncology article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access 11 citations Implementing Pre‐Emptive Pharmacogenetics: Impact of Early Pharmacogenetic Screening in a Pediatric Oncology Cohort of 1,151 Subjects 2025 Clinical Pharmacology & Therapeutics article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access 10 citations Clinical Benefits and Utility of Pretherapeutic DPYD and UGT1A1 Testing in Gastrointestinal Cancer 2024 JAMA Network Open article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access 25 citations Skeletal muscle is independently associated with grade 3–4 toxicity in advanced stage pancreatic ductal adenocarcinoma patients receiving chemotherapy 2024 Clinical Nutrition ESPEN article Medicine Pancreatic and Hepatic Oncology Research Open access 5 citations Pharmacogenetic Panel Testing: A Review of Current Practice and Potential for Clinical Implementation 2024 The Annual Review of Pharmacology and Toxicology review Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access 21 citations Partial protein binding of uracil and thymine affects accurate dihydropyrimidine dehydrogenase (DPD) phenotyping 2024 Journal of Pharmaceutical and Biomedical Analysis article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access 3 citations Personalized Chronomodulated 5‐Fluorouracil Treatment: A Physiologically‐Based Pharmacokinetic Precision Dosing Approach for Optimizing Cancer Therapy 2024 Clinical Pharmacology & Therapeutics article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access 14 citations A Nomogram to Predict Severe Toxicity in DPYD Wild‐Type Patients Treated With Capecitabine‐Based Anticancer Regimens 2023 Clinical Pharmacology & Therapeutics article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access 9 citations Implementation of pre‐emptive testing of a pharmacogenomic panel in clinical practice: Where do we stand? 2023 British Journal of Clinical Pharmacology article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access 29 citations UGT1A1 Genotype-Guided Dosing of Irinotecan: Time to Prioritize Patient Safety 2023 Pharmacogenomics article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access 8 citations Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction of CYP2D6 and COMT with atomoxetine and methylphenidate 2022 European Journal of Human Genetics article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access 27 citations Dutch Pharmacogenetics Working Group Guideline for the Gene-Drug Interaction of CYP2D6 and COMT with Atomoxetine, Methylphenidate and Clonidine 2022 Research Square preprint Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access 1 citations Dutch pharmacogenetics working group guideline for the gene-drug interaction of ABCG2, HLA-B and Allopurinol, and MTHFR, folic acid and methotrexate 2022 European Journal of Human Genetics article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access 37 citations Quantification of uracil, dihydrouracil, thymine and dihydrothymine for reliable dihydropyrimidine dehydrogenase (DPD) phenotyping critically depend on blood and plasma storage conditions 2022 Journal of Pharmaceutical and Biomedical Analysis article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access 21 citations 1–20 of 23 Page 1 / 2 Next → References 0